Quick Answer
OptimizeRx Corp reported Gross Profit of $73.59 million for fiscal year 2025.
OptimizeRx Corp Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $73.59M | +23.9% |
| 2024 | $59.38M | +38.4% |
| 2023 | $42.90M | +10.1% |
| 2022 | $38.97M | +9.3% |
| 2021 | $35.64M | +47.8% |
| 2020 | $24.11M | +56.1% |
| 2019 | $15.44M | +26.5% |
| 2018 | $12.21M | +105.1% |
| 2017 | $5.95M | +37.2% |
| 2016 | $4.34M | +20.6% |
| 2015 | $3.60M | +9.7% |
| 2014 | $3.28M | +16.4% |
| 2013 | $2.82M | +50.4% |
| 2012 | $1.87M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.52M | +30.3% | -6.0% |
| June 30, 2025 | $18.64M | +59.2% | +39.7% |
| March 31, 2025 | $13.34M | +9.3% | -0.8% |
| September 30, 2024 | $13.45M | +37.2% | +14.9% |
| June 30, 2024 | $11.70M | +49.6% | -4.1% |
| March 31, 2024 | $12.20M | +64.2% | +24.5% |
| September 30, 2023 | $9.80M | +4.0% | +25.2% |
| June 30, 2023 | $7.83M | -13.0% | +5.3% |
- OptimizeRx Corp showed an increase of +23.9% in Gross Profit compared to the prior fiscal year.
- Over the 2012–2025 period, OptimizeRx Corp’s gross profit has grown by 3827.7% (from $1.87 million to $73.59 million).
- The most recent figure is from OptimizeRx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: